Half of patients say convenience and access to care are the most important factors influencing their decision-making—and investors are looking to capitalize on this demand for convenience. Last year, venture capital investors poured $1.4 billion into on-demand health care services, including telemedicine companies (e.g., Doctor on Demand) and patient-centered drug delivery (e.g., Nurx and Hims).